51. Scleroderma Clinical trials / Disease details
Clinical trials : 525 / Drugs : 565 - (DrugBank : 148) / Drug target genes : 114 - Drug target pathways : 217
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04334031 (ClinicalTrials.gov) | July 20, 2020 | 10/3/2020 | Deployment o the Multidisciplinary Prospective Cohort Imminent | Deployment o the Multidisciplinary Prospective Cohort Imminent | Chronic Inflammatory Disease;Angioedema;Severe Asthma;Lupus;Atopic Dermatitis;Psoriatic Arthritis;Multiple Sclerosis;Systemic Sclerosis;Behçet Disease | Genetic: Biobanking with genetic analysis;Other: SF-12 questionnaire | University Hospital, Lille | FHU IMMINeNT;FHU PRECISE: Projet Fédératif Hospitalo-Universitaire PREcision health in Complex Immune-mediated inflammatory diseaSEs;Fond de dotation de la Société Française de Dermatologie (SFD) | Recruiting | 18 Years | N/A | All | 2200 | N/A | France |